Table 1 Demographics and basic disease characteristics of F2x patients and controls.
F2x | IIH | RRMS | NMDARE | |
|---|---|---|---|---|
Number of patients (F20/22/23/25) [number/%] | 59 (34/57.6; 6/10.2; 8/13.6; 11/18.6) | 52 | 49 | 16 |
Age (median with range) [years] | 31.0 (18–66) | 33.7 (18–66) | 34.9 (18–55) | 37.0 (18–78) |
Male:female | 1.68:1 | 0.24:1 | 0.48:1 | 0.33:1 |
Pt. first diagnosed [number/%] | 20/33.9 | na | 49/100 | 15/93.8 |
Positive psychotic symptoms (at sample taking) [number/%] | 48/81.4 | 0/0 | 0/0 | 10/62.5 |
Antipsychotic drugs [number/%] | 55/93.2 | na | na | na |
Anti-NMDA receptor ab [number/%] | 0/0 | na | na | 16/100 |
